|
1. Mestinon® (pyridostigmine bromide tablets, USP) package insert, Valeant Pharmaceuticals International.Rev 08/00
|
|
2. The New England Journal of Medicine, D. B. Drachman; Medical progress: myasthenia gravis 1994:330(25):1797-1810M
|
|
3. The Merck Manual Seventeenth Edition, Page 1358, Section 14- Neurologic Disorders, Table 166-1, Examples of Disorders Associated with Defects in Neurotransmission
|
|
4. Myasthenia Gravis Survival Guide, Jeanne Rhynsburger, R.N., Page 13, (This publication has been approved by the Myasthenia Gravis Foundation Medical Advisory Board) Sept 1991
|
|
5. Myasthenia Gravis, Michael W. Nicolle, MD, FRCPC, DPhil, The Neurologist, January 2002, Volume 8, Number 1, page 2-21
|
